Schedule 13G ownership disclosure
MOLECULIN BIOTECH INC
Security class unavailable · CUSIP: 60855D101
Event date: 2018-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,502,350
- Percent of class
- 5.8300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000062
- Form type
- SC 13G
- Filer
- Moleculin Biotech, Inc.
- CIK
- CIK 1659617
- Filed
- Feb 21, 2018
- Reporting period
- Feb 16, 2018
- Description
- Schedule 13G beneficial ownership